Ambrx Biopharma Cayman, Inc. Annual Depreciation in USD from 2021 to 2022

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Ambrx Biopharma Cayman, Inc. quarterly/annual Depreciation history and growth rate from 2021 to 2022.
Ambrx Biopharma Cayman, Inc. Depreciation for the quarter ending June 30, 2023 was $200K, unchanged year-over-year.
Ambrx Biopharma Cayman, Inc. annual Depreciation for 2022 was $800K, a 33.3% increase from 2021.

Depreciation, Annual (USD)

Depreciation, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$800K	+$200K	+33.3%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-30
2021	$600K			Jan 1, 2021	Dec 31, 2021	10-K	2023-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.